APA (7th ed.) Citation

Eisemann, T., Wick, W., Angel, P., & Peterziel, H. (2019). Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma. Neuro-Oncology, 21(3), . https://doi.org/10.1093/neuonc/noy184

Chicago Style (17th ed.) Citation

Eisemann, Tanja, Wolfgang Wick, Peter Angel, and Heike Peterziel. "Podoplanin Expression Is a Prognostic Biomarker but May Be Dispensable for the Malignancy of Glioblastoma." Neuro-Oncology 21, no. 3 (2019). https://doi.org/10.1093/neuonc/noy184.

MLA (9th ed.) Citation

Eisemann, Tanja, et al. "Podoplanin Expression Is a Prognostic Biomarker but May Be Dispensable for the Malignancy of Glioblastoma." Neuro-Oncology, vol. 21, no. 3, 2019, https://doi.org/10.1093/neuonc/noy184.